LifeStance Health Group, Inc. LFST
$12.51
-$0.10-0.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 26.08% | 21.17% | 17.43% | 16.34% | 10.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.08% | 21.17% | 17.43% | 16.34% | 10.56% |
| Cost of Revenue | 19.18% | 19.88% | 18.45% | 16.46% | 10.42% |
| Gross Profit | 41.14% | 23.81% | 15.41% | 16.08% | 10.86% |
| SG&A Expenses | 10.12% | 6.16% | 1.81% | 12.70% | 2.77% |
| Depreciation & Amortization | 1.73% | -3.18% | -8.43% | -10.31% | -24.70% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.94% | 15.01% | 12.45% | 14.14% | 6.22% |
| Operating Income | 1,169.97% | 1,294.64% | 959.53% | 1,710.86% | 81.02% |
| Income Before Tax | 562.08% | 1,444.22% | 271.28% | 184.95% | 73.73% |
| Income Tax Expenses | 278.75% | 353.19% | 300.40% | 507.83% | -427.90% |
| Earnings from Continuing Operations | 722.84% | 1,908.89% | 264.06% | 118.08% | 83.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 722.84% | 1,908.89% | 264.06% | 118.08% | 83.71% |
| EBIT | 1,169.97% | 1,294.64% | 959.53% | 1,710.86% | 81.02% |
| EBITDA | 314.37% | 132.34% | 92.61% | 34.61% | 261.31% |
| EPS Basic | 728.57% | 1,944.44% | 260.96% | 117.83% | 84.01% |
| Normalized Basic EPS | 589.58% | 1,470.83% | 287.79% | 189.02% | 72.73% |
| EPS Diluted | 700.00% | 1,944.44% | 246.77% | 114.00% | 83.69% |
| Normalized Diluted EPS | 584.38% | 1,445.83% | 283.21% | 187.80% | 72.73% |
| Average Basic Shares Outstanding | -0.83% | 1.04% | 1.72% | 1.74% | 1.93% |
| Average Diluted Shares Outstanding | 0.15% | 1.13% | 4.09% | 2.24% | 1.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |